| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/29/2007 | CN101027282A Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 08/29/2007 | CN101027050A Oral pharmaceutical for dry skin prevention or remedy |
| 08/29/2007 | CN101027048A Medicinal composition as immunosuppressant |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/29/2007 | CN101024626A Intermediate synthesizing compound for preparing atorvastatin calcium |
| 08/29/2007 | CN101024625A Ketopyrrolidine sulfurate in liquid and its prpearing method |
| 08/28/2007 | US7262308 Resolution agent free; chemical intermediates for production of |
| 08/28/2007 | US7262307 Chemical intermediate for cephalosporin bactericides |
| 08/28/2007 | US7262207 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
| 08/28/2007 | US7262202 2-substituted 4-pyrrolyl-pyrimidines, e.g., 2-[N-(phenyl)]-4-(2,4-dimethylpyrrol-3-yl)pyrimidineamines in which the phenyl group is 2-, 3-, 4-or 5-substituted by at least one of F, NH2, NO2, OH, Cl, Br, I, CN, CH2OH, CF3 or OMe. |
| 08/28/2007 | US7262183 Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases |
| 08/28/2007 | US7262156 1-Oxazolidin-3-yl-3-(o-amino- or hydroxyphenyl-propenone derivatives, e.g., 1-[2-(2,4-Dimethyl-cyclohex-3-enyl)-oxazolidin-3-yl]-3-(2-hydroxy-phenyl)-propenone; for use in laundry detergents, perfumes, shampoos, and hair conditioners |
| 08/28/2007 | US7261954 Organo-transition metallic complex having a coordinating carbon such as bis(2-(4,6-difluorophenyl)pyridyl-N,C2 ')iridium(III) picolinate and gallium(III)tris[2-(((pyrrole-2-yl)methylidene)amino)ethyl]amine |
| 08/28/2007 | CA2389858C New cyclic derivatives of .alpha.-amino-.gamma.-hydroxy-amides, the process for the preparation thereof and the pharmaceutical compounds which contain them |
| 08/28/2007 | CA2212242C Stable arylpyrrole particles, process for their preparation and suspension concentrate compositions comprising them |
| 08/23/2007 | WO2007094467A1 N-vinyl-2-pyrrolidone having excellent storage stability, and method for production thereof |
| 08/23/2007 | WO2007093211A1 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound |
| 08/23/2007 | US20070197798 Process for producing cyclic n-hydroxy imide compounds |
| 08/23/2007 | US20070197794 Method for preparing pyrrolidine oximes |
| 08/23/2007 | US20070197791 Method for the preparation of dicarboxylic lmides |
| 08/23/2007 | US20070197632 Aminocyclohexyl ether compounds and uses thereof |
| 08/23/2007 | US20070197620 Methods for treating CNS disorders with bicyclo-substituted 2-imidazoline and 2-imidazoles |
| 08/23/2007 | US20070197586 8-Hydroxy-5-[(-Hydroxy-2-[[ (1R)-2-(4-Methoxyphenyl)-1-Methylethyl] Amino][Ethyl]-2(1H)-Quinolinone Monohydrochloride In Crystalline Form And The Process For Its Preparation |
| 08/23/2007 | US20070197561 Inhibitors of nucleoside metabolism |
| 08/23/2007 | US20070197522 Dpp-iv inhibitors |
| 08/23/2007 | US20070197516 modulators of monocyte chemotactic proteins (MCP-1), such as N-(2-(((S)-1-((2S,3S)-3-hydroxy-1-(isobutylamino)hexan-2-yl)-2-oxopyrrolidin-3-yl)carbamoyl)-4-(trifluoromethyl)phenyl)azetidine-1-carboxamide, useful for the prevention of asthma, multiple sclerosis, atherosclerosis and rheumatoid arthritis |
| 08/23/2007 | US20070196908 Stabilizers For Polymerizable Biocompatible Materials |
| 08/23/2007 | US20070196360 Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors |
| 08/22/2007 | EP1820795A1 Novel anthranilic acid derivative or salt thereof |
| 08/22/2007 | EP1820501A1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 08/22/2007 | EP1819721A1 Microcin b17 analogs and methods for their preparation and use |
| 08/22/2007 | EP1819679A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 08/22/2007 | EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors |
| 08/22/2007 | EP1819342A1 Quinoline tachykinin receptor antagonists |
| 08/22/2007 | EP1756052A4 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 08/22/2007 | EP1699900A4 Composition and method for preventing fouling in (meth)acrylic acid processes |
| 08/22/2007 | EP1651657B1 Biphosphine ruthenium complexes with chiral diamine ligands as catalysts |
| 08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
| 08/22/2007 | EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 08/22/2007 | EP1067138B1 Hydroxyproline derivatives |
| 08/22/2007 | CN1332954C Dipeptidyl peptidase IV effectors |
| 08/22/2007 | CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 08/22/2007 | CN1332915C Method for recovering solvent from alkine in high-grade |
| 08/22/2007 | CN101023091A Coupling agents comprising a photolabile protecting group and uses thereof, such as for the functionalisation of solid supports |
| 08/21/2007 | US7259184 Treatment of arrhythmia and the production of analgesia and local anesthesia by administering 1-[2-(3,4-dimethoxyphenyl)ethoxy]-2-(3-hydroxy-1-pyrrolidinyl)cyclohexane or a salt |
| 08/21/2007 | US7259167 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof |
| 08/21/2007 | US7259158 Naphthaline derivatives as H3 inverse agonists |
| 08/21/2007 | US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| 08/16/2007 | WO2007092558A2 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/16/2007 | WO2007091528A1 Novel dioctatin derivatives and process for production thereof |
| 08/16/2007 | WO2007091046A1 Chemical compounds |
| 08/16/2007 | US20070191468 Amino alcohol compound |
| 08/16/2007 | US20070191395 Heterocyclic compounds having antifungal activity |
| 08/16/2007 | US20070191341 N-Substituted Benzene Sulfonamides |
| 08/16/2007 | US20070191281 Compound containing a labile disulfide bond |
| 08/16/2007 | US20070190662 Acoustic sensors and methods |
| 08/16/2007 | US20070189970 Contrast medium for thrombus formation |
| 08/16/2007 | US20070187649 For inhibiting polymerization of ethylenically unsaturated monomers; includes a water-soluble phenylenediamine composition |
| 08/16/2007 | CA2641520A1 Novel dioctatin derivatives and process for production thereof |
| 08/16/2007 | CA2640229A1 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817282A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 08/15/2007 | EP1817281A1 N- [(3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors |
| 08/15/2007 | EP1569896B1 Tetrahydro-naphthalene derivatives |
| 08/15/2007 | EP1322596B1 Zwitterionic tachykinin receptor antagonists |
| 08/15/2007 | CN1331866C Method for continuous extracting chlorophyll from silkworm dropping |
| 08/15/2007 | CN1331853C Small molecule inhibitors of rotamase enzyme activity |
| 08/15/2007 | CN1331852C Synthesis method of N-substituted-3-amidopyrrolidine and its bihydrochlorate |
| 08/15/2007 | CN101018768A Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 08/15/2007 | CN101016260A Chirality sulfonamide aminol ligand based on prolinol, its preparing method and application |
| 08/15/2007 | CN101016254A Chemical synthesis method for nitriles substance |
| 08/14/2007 | US7256419 Composition for forming organic insulating film and organic insulating film formed from the same |
| 08/14/2007 | US7256219 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2007 | US7256216 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 08/14/2007 | US7256212 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 08/14/2007 | US7256211 Containing a carboxy-substituted thiazolylthio group, e.g., 15 alpha ,13E)-9-oxo-15-hydroxy-16-(4-fluoro-3-phenylphenyl)-5-(4-carboxythiazol-2-yl)-1,2,3,4,17,18,19,20-octanol-5-thia-8-azaprost-13-ene; EP4 agonistic action and are useful for treating diseases including immunological disorders and asthma |
| 08/14/2007 | US7256191 Materials and methods for the treatment of depression |
| 08/14/2007 | US7256186 Alzheimer's disease, or other diseases relating to amyloid deposits; neurodegenerative diseases |
| 08/14/2007 | US7256158 Animal husbandry; veterinary medicine |
| 08/14/2007 | CA2271607C Process for stabilizing cyanohydrins |
| 08/14/2007 | CA2213714C Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/14/2007 | CA2206758C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/14/2007 | CA2193398C Benzocycloalkene compounds, their production and use |
| 08/09/2007 | WO2007088571A2 A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest |
| 08/09/2007 | WO2007088553A1 Process for the preparation of amorphous atorvastatin calcium salt |
| 08/09/2007 | WO2007087906A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 08/09/2007 | WO2007087717A1 Viral polymerase inhibitors |
| 08/09/2007 | WO2006087476A3 1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics |
| 08/09/2007 | US20070185337 Process for the preparation of optically pure 4-hydroxy-2-oxo-1-pyrrolidine acetamide |
| 08/09/2007 | US20070185336 Process for preparing n-protected 4-ketoproline derivatives |
| 08/09/2007 | US20070185189 Prolinylarylacetamides |
| 08/09/2007 | US20070185112 Piperidine/piperazine-type inhibitors of p38 kinase |
| 08/09/2007 | US20070184979 Novel sulfonylpyrroles |
| 08/09/2007 | CA2638784A1 Viral polymerase inhibitors |
| 08/09/2007 | CA2638014A1 A process for resolving racemic mixtures and a diastereoisomeric complex of a resolving agent and an enantiomer of interest |
| 08/09/2007 | CA2632870A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 08/08/2007 | EP1814875A2 Improved inhibitors for the soluble epoxide hydrolase |
| 08/08/2007 | EP1814850A1 New histone deacetylases inhibitors |